Editas Medicine Inc (EDIT)
$2.67 -8.87% Close Oct 30, 2026 Live
Editas Medicine stock today
Editas Medicine closed at $2.67 on October 30, 2026, down 8.87% on the day. Over the past year it returned -11.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $261 million.
$2.00$3.00
NovJan 2026MarMayJulSep
| Period | EDIT | S&P 500 (SPY) |
|---|---|---|
| 1 month | +3.9% | -0.9% |
| 3 months | -0.7% | +2.1% |
| Year to date | +30.2% | +11.7% |
| 1 year | -11.3% | +12.4% |
| 3 years | -57.8% | +88.5% |
| 5 years | -92.7% | +76.0% |
Key statistics
- Market value
- $261M
- Price / sales
- 5.6
- 52-week range
- $1.67 to $3.75
- Next report
- Nov 9, 2026 (estimated)
About Editas Medicine
Editas Medicine Inc develops gene-editing therapies for genetic diseases.
Sector: Health Care
More on Editas Medicine
- Financials: revenue, earnings and segmentsRevenue +25% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $203.82 today
No forecast, no recommendation. This page describes Editas Medicine Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.